Anxiety treatment serving Deerfield Beach — exposure-based CBT, in-house psychiatry.

RECO Health's Delray Beach campus is 22 minutes north of Deerfield Beach — close enough to keep family and work reachable, far enough to establish structured treatment. Clients from The Cove, Cresthaven, and Hillsboro Beach receive disorder-specific care: GAD, panic disorder, social anxiety, and OCD each treated with the exposure protocol matched to it rather than folded into a generic anxiety group. In-house psychiatry manages SSRI pharmacotherapy at anxiety-appropriate doses, and benzodiazepines are avoided in clients with any substance use history.

Deerfield Beach sits 13 miles south of RECO Health’s Delray Beach campus along the A1A corridor — roughly 22 minutes by car. For clients living in The Cove, Pioneer Park, Cresthaven, Hillsboro Beach, or Goldcoast Centre, that drive is short enough to keep family and work reachable while giving structured treatment its own clinical container. RECO treats anxiety disorders at the partial hospitalization (PHP) and intensive outpatient (IOP) levels of care, with in-house psychiatry, disorder-specific therapy protocols, and integrated addiction services under one roof.

Disorder-specific assessment before treatment starts

“Anxiety” is a symptom, not a diagnosis. Before a treatment plan is written, intake clinicians use structured, validated instruments to separate what is actually driving the presentation. The GAD-7 quantifies generalized anxiety severity, the PDSS tracks panic frequency and functional interference, the LSAS maps social anxiety across performance and interaction domains, and the Y-BOCS identifies OCD symptom burden and insight. A PHQ-9 screens for co-occurring depression, and the ASRS is added when adult ADHD may be maintaining the picture.

The distinction matters clinically. Generalized anxiety responds to a different exposure structure than OCD. Social anxiety treatment collapses when it is folded into a generic “anxiety group” and run as psychoeducation. Panic disorder without agoraphobia responds to a shorter, more focused protocol than panic with pervasive avoidance. Every plan at RECO names the primary DSM-5-TR diagnosis, the concurrent conditions, and the specific outcome measure that will be repeated at intake, mid-course, and discharge.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine are all FDA-approved for one or more anxiety disorders and remain first-line pharmacotherapy for GAD, panic disorder, social anxiety, and OCD. Anxiety-effective dosing typically sits at the upper end of the depression range — sertraline 150-200 mg, escitalopram 20 mg, fluoxetine 40-60 mg — with OCD dosing often higher still. RECO’s psychiatrists start low and titrate slowly to blunt the paradoxical activation and jitteriness that drives patients off the medication in the first two weeks.

Augmentation strategies are selected by disorder rather than by pattern. Buspirone is used for GAD partial responders. Hydroxyzine serves as the preferred as-needed option for acute distress in clients who cannot safely take benzodiazepines. Propranolol has a defined role in situational performance anxiety. For OCD non-responders, low-dose aripiprazole or risperidone augmentation is considered after adequate SSRI trials at maximum tolerated dose for twelve weeks. Medication is one lever in the plan, not the plan itself.

Exposure-based CBT is the therapy that works

For every anxiety disorder in the DSM-5-TR, the evidence base points to exposure-based cognitive behavioral therapy rather than supportive talk therapy. For OCD, that means Exposure and Response Prevention — structured hierarchies, therapist-guided in-session exposures, and homework that carries the work into daily life. Ritual prevention is the mechanism; discussing the obsession without blocking the compulsion does not produce durable change.

Panic disorder is treated with interoceptive exposure — deliberately provoking the feared bodily sensations (rapid breathing, elevated heart rate, dizziness) so that catastrophic misinterpretation extinguishes. Social anxiety is treated with graded in-vivo exposures paired with cognitive restructuring targeting probability and cost overestimation. Generalized anxiety uses worry exposure, uncertainty tolerance work, and applied relaxation. RECO’s therapists run these protocols during individual sessions; group programming — including a dedicated anxiety treatment track, ACT skills, and DBT distress tolerance modules — supports and reinforces the individual exposure work rather than replacing it.

Why we don’t lean on benzodiazepines

Benzodiazepines — alprazolam, lorazepam, clonazepam, diazepam — reliably relieve acute anxiety within thirty to sixty minutes. That fast relief is exactly the problem in exposure-based treatment. Benzodiazepines blunt the extinction learning that makes CBT work; a patient who takes lorazepam before a feared situation does not learn that the feared situation is survivable without lorazepam. State-dependent learning further degrades generalization to unmedicated contexts.

The risk profile is also poorly matched to RECO’s population. A substantial share of clients carry co-occurring substance use disorders, and benzodiazepine dependence develops on therapeutic dosing within weeks. When situational bridging is genuinely needed — a court date, a flight, an unavoidable exposure early in treatment — hydroxyzine, gabapentin, a low-dose beta-blocker, or a short course of a non-benzodiazepine sedative cover most cases without the dependence trajectory. Benzodiazepines are prescribed judiciously and never as maintenance therapy in clients with any substance use history.

When anxiety and substance use co-occur

A meaningful share of clients presenting to RECO for anxiety have been medicating anxiety with alcohol, cannabis, or benzodiazepines obtained on or off prescription. That pattern has to be named directly. Alcohol and cannabis provide short-term anxiolysis and drive rebound anxiety over the following twenty-four to seventy-two hours, and benzodiazepine tolerance produces interdose withdrawal that presents clinically as worsening anxiety. Treating the anxiety without addressing the substance rarely produces durable improvement.

Integrated care runs both tracks simultaneously. Medically monitored withdrawal is arranged through RECO’s detox program when clinically indicated — CIWA-guided management for alcohol and structured tapers for benzodiazepines. Naltrexone or acamprosate is offered for alcohol use disorder; buprenorphine is available where opioids are involved. Anxiety-focused CBT begins in parallel rather than being deferred until sobriety is “established,” consistent with the modern integrated-treatment standard.

What to expect on your first visit

The first appointment is a ninety-minute biopsychosocial evaluation with a licensed clinician followed by a same-day psychiatric evaluation. Symptom rating scales appropriate to the presentation are administered, medical and medication history is reviewed, prior treatment records are requested, and any substance use is assessed against ASAM Criteria dimensions to determine the appropriate level of care. Family members are welcome to join for a portion of the intake with the client’s consent.

By the end of the first day, clients leave with a working DSM-5-TR diagnosis, a written treatment plan naming the outcome measure that will be tracked, a psychiatric medication plan if indicated, and a program schedule. Care coordination begins immediately for clients continuing to work or attend school in Deerfield Beach — most IOP schedules are structured to preserve employment.

Insurance and admissions from Deerfield Beach

RECO Health is in-network with most major commercial carriers, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification of benefits is completed the same business day intake is requested, and the admissions team provides a written estimate of member responsibility before treatment begins so families are not surprised by out-of-pocket exposure. Single-case agreements with out-of-network carriers are considered for clinically appropriate cases.

For Deerfield Beach residents, the drive up I-95 or A1A to the Delray Beach campus takes roughly 22 minutes outside of rush hour. Transportation assistance is available for clients whose anxiety symptoms — particularly panic with driving avoidance or agoraphobia — make independent driving impractical in the first weeks of treatment.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.